ImmunityBio, Inc. (IBRX) Insider Trading

Name: ImmunityBio, Inc. (IBRX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 6, 2026): Barry J. Simon (Director): Sale of 25,000 shares, $268.8K.

Get alerted when insiders trade IBRX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta